P27707 (DCK_HUMAN) Homo sapiens (Human)

Deoxycytidine kinase UniProtKBInterProSTRINGInteractive Modelling

260 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: F5CTF3

Available Structures

47 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
S74E-R104M-D133A dCK variant in complex with L-deoxythymidine and UDP Heteromer
UDP;LLT;19-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the F2.4.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-…homo-2-mer18V;UDP;18-260
Assess
C4S dCK variant of dCK in complex with L-dC+ADPhomo-2-merADP;LDC;19-260
Assess
C4S dCK variant of dCK in complex with gemcitabine+ADPhomo-2-merADP;GEO;19-260
Assess
The structure of deoxycytidine kinase complexed with lamivudine and ADP.homo-2-merADP;3TC;19-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the F2.2.1 inhibitoR (2-[({2-[3-(2-FLUOROETHOXY)-…homo-2-merUDP;1NO;19-260
Assess
C4S dCK variant of dCK in complex with FTC+ADPhomo-2-merADP;ETV;19-260
Assess
C4S dCK variant of dCK in complex with D-dC+ADPhomo-2-merADP;DCZ;19-260
Assess
Structure of human dCK complexed with 2'-Deoxycytidine and ADP, Space group C 2 2 21homo-2-merADP;DCZ;19-260
Assess
Human dCK complex with 5-Me dC and ADPhomo-2-merADP;MCY;19-260
Assess
S74E dCK in complex with 5-bromodeoxycytidine and UDPhomo-2-merUDP;5BT;19-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 4 [1-[5-(4-{[(2,6-diaminopyrimidin-…homo-2-mer2XJ;UDP;19-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the F2.1.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-…homo-2-mer1NM;UDP;19-260
Assess
The structure of deoxycytidine kinase complexed with troxacitabine and ADP.homo-2-merADP;LTT;19-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the F2.3.1 inhibitor (2-[({5-ETHYL-2-[3-(2-FLUORO…homo-2-mer1NN;UDP;19-260
Assess
S74E-dCK mutant in complex with UDPhomo-2-merUDP;19-260
Assess
C4S-E247A dCK variant of dCK in complex with cladribine+ADPhomo-2-merADP;CL9;19-260
Assess
Crystal structure of dCK mutant C3S in complex with masitinib and UDPhomo-2-merUDP;G65;DCM;19-260
Assess
Structure of human dCK complexed with cytarabine and ADP-MGhomo-2-merMG;AR3;ADP;20-260
Assess
C4S dCK variant of dCK in complex with L-dA+UDPhomo-2-merUDP;3L1;20-260
Assess
C4S dCK variant of dCK in complex with D-dA+UDPhomo-2-merUDP;3D1;20-260
Assess
C4S dCK variant of dCK in complex with cladribine+UDPhomo-2-merUDP;CL9;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 10 {2-{[(1R/S)-1-{2-[3-(2-fluoroeth…homo-2-mer2Y8;2Y7;UDP;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 6 {2-[5-(4-{[(4,6-diaminopyrimidin-…homo-2-mer2XZ;UDP;20-260
Assess
Structure of human dCK complexed with gemcitabine and ADP-MGhomo-2-merMG;ADP;GEO;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the DI-43 inhibitorhomo-2-mer1UX;UDP;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 8 {2,2'-[{4-[(2R)-4-{[(4,6-diaminop…homo-2-mer2XM;UDP;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 9 {2-{[(1R)-1-{2-[3-(2-fluoroethoxy…homo-2-mer2Y1;UDP;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the DI-39 inhibitorhomo-2-mer1QC;UDP;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 5 {5-(4-{[(4,6-DIAMINOPYRIMIDIN-2-Y…homo-2-mer2XL;UDP;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 12R {N-{2-[5-(4-{(1R)-1-[(4,6-diami…homo-2-merUDP;2XN;20-260
Assess
C4S dCK variant of dCK in complex with L-dA+ADPhomo-2-merMG;3L1;ADP;20-260
Assess
Human dCK complex with Acyclic Nucleosidehomo-2-merAC2;UDP;20-260
Assess
Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 7 {N-(2-(3-(4-(((4,6-diaminopyrimid…homo-2-mer2Y0;UDP;20-260
Assess
Structure of human dCK complexed with 2'-Deoxycytidine and ADP, P 43 21 2 space grouphomo-2-merADP;DCZ;20-260
Assess
C4S-E247A dCK variant of dCK in complex with D-dA+ADPhomo-2-merADP;3D1;20-260
Assess
Crystal structure of human dCK R104M/D133A in complex with L-dT and ADPhomo-2-merADP;LLT;20-260
Assess
Crystal structure of human dCK complexed with clofarabine and ADPhomo-2-merMG;ADP;CFB;20-260
Assess
Crystal Structure of human deoxycytidine kinase in complex with deoxycytidine and uridine diphospha…homo-2-merCA;MG;DCZ;UDP;20-260
Assess
Crystal structure of human deoxycytidine kinase in complex with deoxycytidinehomo-2-merCA;DCZ;20-260
Assess
Crystal structure of dCK mutant C3S in complex with imatinib and UDPhomo-2-merUDP;STI;MG;DCM;20-260
Assess
Human Deoxycytidine kinase dCMP, UDP, Mg ion product complexhomo-2-merMG;UDP;DCM;20-260
Assess
Human Deoxycytidine kinase dAMP, UDP, Mg ion product complexhomo-2-merMG;UDP;D5M;20-260
Assess
Crystal structure of dCK mutant C3Shomo-2-merUDP;UMP;MG;20-260
Assess
C4S dCK variant of dCK in complex with D-dG+UDPhomo-2-merGNG;UDP;21-260
Assess
X-Ray structure of Human Deoxycytidine Kinase in complex with ADP and an inhibitormonomerADP;B86;MG;20-260
Assess
X-Ray structure of Human Deoxycytidine Kinase in complex with an inhibitormonomerMLT;B87;20-260
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomerMG;UDP;D5M;0.832qro.1.A20-260
100.00
Assess

Alignments